Back to search

Norway· NO-ID_DEF9F7E2-86B9-43CA-BDA9-002FDFB68371

Red Yeast Rice solaray

A lipid modifying agents product containing red yeast rice, registered in Norway by Solaray.

ATC C10

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedRed Yeast Rice solarayATCC10REGISTER NO.NO-ID_DEF9F7E2-86B9-4…PACKS LISTED2CHECKEDOctober 2, 2026

The record

At a glance

FEST (Norway)
Active substance
Red Yeast Rice
Manufacturer
Solaray
Country
Norway (NO)
ATC code
C10
ATC class
LIPID MODIFYING AGENTS
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
October 2, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_DEF9F7E2-86B9-43CA-BDA9-002FDFB68371
  • no_varenummer
    229820
    90

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under C10

Lipid modifying agents, as other registers publish it.

All red yeast rice products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/90bd0f10-6304-46c1-8441-4d421e464483
GET /v1/drugs/90bd0f10-6304-46c1-8441-4d421e464483?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsel, hard",
  "source": "fest",
  "status": "A",
  "atc_name": "Lipidmodifiserende midler",
  "merkevare_id": "ID_DEF9F7E2-86B9-43CA-BDA9-002FDFB68371",
  "name_form_strength": "Red Yeast Rice solaray kaps 600 mg",
  "prescription_group": "C"
}

See everything about red yeast rice.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.